, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

I’ve got many friends in the Intelligence Community so I’m I’m kind of a pretty Deep Insider in terms of the government I know Tony Fauci personally I’ve dealt with him my whole career” (Robert Malone, MS-MD)

Robert Malone, MS-MD, has become the darling of so-called “conservative” media. RW Malone MD, LLC partners include, or have included, “BehaviorMatrix, LLC, a Philadelphia, Pennsylvania area technology company specializing in understanding human emotion and behavioral cues from digital communication”. He has worked for CIA connected DynCorp on smallpox trials, shortly after it was accused of human trafficking; helped fast-track an Ebola vaccine, and even calls himself a “Deep Insider”. Recall that while Malone says that the mRNA Covid vaccines are dangerous, he non-sensically says that those above 60 and high risk individuals should be injected, anyway. Based on his CV and his interviews, Malone is more deep state than the so-called deep state. He’s so deep state it’s unclear what he is.

RW Malone’s helping the world’s second largest conglomerate (Reliance, India) and the richest man in India, and even Asia, make a vaccine for Covid-19 and he chooses the word “Pariah”, (Dalit-untouchable), to describe the reaction to his criticisms of competitor mRNA vaccines! LOL! Did Malone’s upper caste-upper class Hindu Masters suggest that word or did he think it up himself? Or is Malone working with US Intelligence still? Neither Americans nor India should trust this Malone. He’s paid by the US Dept. of Defense and India’s Reliance Industries, so what is he really up to? You don’t need Malone to tell you that the mRNA vaccines are a risky unknown. By now, even a pet dog could figure out that if the owner fills the yard with unknown stray dogs who eat its food, and then the owner chases it around with a syringe, then something is not right and the pet dog would make a run for it!

Update-Clarification Note: In 1997, DynPort was created as a joint venture of DynCorp and Porton International Inc. Malone worked for DynPort re the smallpox vaccine from 2002-2003. The vaccine was tested at the U. of Kentucky Med Center on volunteers (students at the University of Kentucky and the surrounding community), rather than on the military. In 2004, CSC became the parent company, which later merged with SRA International to become CSRA Inc. DynPort was (is?) the prime contractor of the US Dept. of Defense Joint Vaccine Acquisition Program.

Malone worked for DynPort (DynCorp) with its Smallpox clinical research. This was shortly after it was accused of human trafficking in Bosnia, but he had no apparent ethical qualms about working for DynCorp: “Speaking to the Observer last week, Bolkovac said: “The thing that stood out about these cases in Bosnia, and cases that have been reported in other [UN] mission areas, is … that police and humanitarian workers were frequently involved in not only the facilitation of forced sexual abuse, and the use of children and young women in brothels, but in many instances became involved in the trade by racketeering, bribery and outright falsifying of documents as part of a broader criminal syndicate.” https://www.theguardian.com/world/2012/jan/15/bosnia-sex-trafficking-whistleblower

Malone seems to be a serial entrepreneur and has set up short-lived companies. Were they shell companies for the CIA? Is he US Intel? Mafia? Or what? Simply a hired gun consultant? “DynCorp, which last year was bought by another giant government contractor, the California-based Computer Sciences Corp., holds contracts with more than 40 federal agencies including the Pentagon, State Department, Drug Enforcement Administration, Department of Energy and the Justice Department. Public records show that DynCorp, which hires former Special Operations military personnel and CIA operators and contracts them back to the government, is linked to at least 50 subsidiaries and satellite companies across the U.S. and around the world. Some of the scores of lawsuits brought against DynCorp over the years suggest that it also has worked through companies whose ownership and connections cannot be traced, possibly on behalf of the CIA.” See: “Contractor tries to avert repeat of Bosnia woes” By John Crewdson and Tribune senior correspondent, Chicago Tribune April 19, 2003 https://archive.ph/CpMU1

From Malone’s CV-Resume:
Dynport Vaccine Company, LLC Associate Director, Clinical Research 2002-2003 • Served as liaison between product development teams and clinical research support groups. • Prepared planning documents and product development plans. • Participated in and supported safety review and assessment of smallpox vaccine product. • Identified new technologies relevant to product development teams, facilitating integration of same in product development plans. • Created documents for clinical trials including investigator brochures. Prepared proposal solicitations, technical review of subcontractor proposals. Performed technical review of potential subcontractors, new technologies. • Assisted business development group in strategic evaluation and planning concerning new business opportunities and managed in-house Publication….
Uniformed Services University of the Health Sciences Dept of Surgery, Clinical Breast Care Program (CBCP) through the Henry M. Jackson Foundation Adjunct Associate Professor Chief of Laboratory Science and Director of Tissue Banking 2000-2001 • Worked closely with architect firm to design space, set-up laboratory facilities for the Clinical Breast Care Project, including new facilities design (tissue banking facilities, laboratory, animal rooms, animal surgical suite, office suites) at USUHS and Windber Medical Center, PA • Hired faculty, technicians, staff for CBCP at both sites, including writing and initiating job descriptions, job interviews, hiring decisions, set-up for re-locations • Laboratory Supervisor: Tissue banking immunology, cell culture, gene transfer, genetic vaccination research, animal research
“ See pages upon pages of his CV here: https://ia601408.us.archive.org/12/items/gov.uscourts.flmd.395057/gov.uscourts.flmd.395057.30.6.pdf The original smallpox vaccines used calves, but are apparently good for a lifetime in the majority of cases. The new smallpox vaccines use human fetal tissue. [Update note: The newest third generation Jynneos vaccine does NOT use fetal tissue. However, the Dynport vaccine did.]

Excerpt from RW Malone interview with Joe Rogan, as submitted to the US Congressional Record (public domain) “and I went to work for a company called Dynport vaccine company that had the prime systems contract as government speak for all the biodefense products for the Department of Defense for advanced development which is to say clinical trials through licensure… and so since then for the last I guess about 20 years I’ve been focused on actually doing stuff regulatory affairs, clinical development, getting necessary training, etc. completed a fellowship at Harvard University medical school in uh global as a Global Clinical Scholar to round out my CV and I’ve uh run you know over 100 clinical trials mostly in the vaccine space but also in drug repurposing I’ve been involved in every major outbreak since AIDs this is kind of what I do um I’ve won literally billions of dollars in Federal Grants and Contracts. I’m often brought in by NIH to serve as a study section chair for awarding you know 80 to 120 million dollar contracts in vaccines and biodefense I’ve spent countless hours at the CDC at the AC ACIP meetings um I have multiple friends at the CDC. I work closely with Defense Threat Reduction Agency which is a and it’s one of my favorite uh clients partners teaming partners and I work with the Chem Biodefense Group there’s other branches um including the other this is not the branch that funded the Wuhan Labs that’s another branch of DTRA um I’ve got many friends in the Intelligence Community so I’m I’m kind of a pretty Deep Insider in terms of the government I know Tony Fauci personally I’ve dealt with him my whole career and then and then we had this particular outbreak and um I was uh tip of the spear on bringing the Ebola Vaccine forward that we now call the Merck Ebola Vaccine I’m the one that got Merck involved.

JR: now when the pandemic broke out previous to thatI mean you’re you’re kind of thought of as a heretic now in some strange way…

RM: Pariah
Robert Malone also states that he “had Chinese connections the Chinese protocol for treating this virus I got it in late February and I sent it in to my buddies at the CIA and at DTRA…” Interview transcript entered into the US Congressional Record by US Congressman Nehls: https://d12t4t5x3vyizu.cloudfront.net/nehls.house.gov/uploads/2022/01/JRE-Rogan-Malone-Transcript.pdf

RW Malone Advising Richest Asian on New Covid-19 Vaccine While Making Rounds Criticizing Competitor mRNA Vaccines

RW Malone MD, LLC partners include, or have included: “The VaporBar” and “BehaviorMatrix” https://archive.fo/yI40k

What is Behavior Matrix?Element Data Acquires BehaviorMatrix Technology And Patent To Quantify Human Emotion And Behavior” Oct 04, 2017, 08:57 Seattle, Oct. 4, 2017 /PRNewswire/ — Element Data, Inc., a decision support software platform that harnesses artificial intelligence and machine learning has acquired the assets and patent of BehaviorMatrix, LLC, a Philadelphia, Pennsylvania area technology company specializing in understanding human emotion and behavioral cues from digital communication

Why is RW Malone, in conjunction with so-called “conservative” media outlets, trying to spin the Hanta outbreak in China? More vaccines? Is he planning to transfer US Defense funded tech to Reliance of India or something even more nefarious?
“The Global Times, which has close ties to CCP mouthpiece the People’s Daily, quoted a medical staff member at the infection unit of the First Affiliated Hospital of Xi’an Jiaotong University as saying that the hospital had admitted a patient with non-life-threatening hemorrhagic fever in the past few days.

“Hemorrhagic fever is a common infectious disease in northern China,” the paper said. “Starting from October every year, some areas of Shaanxi [of which Xi’an is the provincial capital] enter the high incidence season of hemorrhagic fever.”

The disease, also known as epidemic hemorrhagic fever, is caused by hantavirus, with rodents as the main source of infection, it said.

Wang said some restrictions were already in place ahead of Thursday’s lockdown, as China pursues a zero-COVID strategy ahead of the 2022 Winter Olympics in Beijing.

“What I’m really worried about this time around is that we don’t know how long this lockdown will go on for; there’s the question of getting hold of supplies,” she said. “Even if we can get them, the prices will go up.” https://www.rfa.org/english/news/china/surge-12232021120335.html You can look through studies online – Hanta is prevalent in parts of China.

Hanta DNA Vaccine: https://www.usamriid.army.mil/press_releases/Final_Hooper_PLoS_ONE_2012.pdf

These Malone patents may or may not be related to the Hanta vaccine. We would have to read more. This patent would probably have expired in 2020 but could probably have been extended, if it were incorporated into the Hanta vaccine patent.

DNA vaccines for eliciting a mucosal immune response 
Patent number: 6110898 
Abstract: The invention consists of a method for inducing production of a mucosal immune response in a host by administration of an antigen-encoding polynucleotide preparation, comprising DNA or RNA encoding an antigenic epitope to a mucosal inductor site in the mucosal tissue of the host. Naked DNA may be administered directly to mucosa, for instance in saline drops, or in a recombinant gene expression vector. Preferably, the recombinant gene expression vectors are not capable of replication or dessimination. The invention also includes the use of live viral vaccines wherein the viruses include immunostimulatory polynucleotides of the invention. According to a preferred method of the invention, a target protein antigen is administered through its expression by a recombinant gene expression vector. 
Type: Grant 
Filed: May 23, 1997 
Date of Patent: August 29, 2000 
Assignee: University of Maryland, Baltimore 
Inventors: Robert W. Malone, Jill G. Malone

Update-Clarification References
DynPort Vaccine Co., a joint venture between Reston, Va.-based Dyncorp and Porton International, is about to begin wide-scale testing of its new smallpox vaccine.” See: “Dyncorp unit to test smallpox vaccine” Apr 26, 2002, Washington Business Journal https://archive.fo/JWssi

Dynport completes Phase I smallpox vaccine clinical trial” April 19, 2003 PharmaBiz https://archive.md/roRha

DynPort is a contractor for the Medical Countermeasure Systems Joint Vaccine Acquisition Program. The company is developing therapeutics to protect against emerging infectious diseases, biological and chemical warfare threat agents, and seasonal and pandemic influenza. The company was formed in 1997 as a joint venture between DynCorp, which was later acquired by CSC (NYSE: CSC) and Porton International Inc.
In 2004, CSC acquired Porton’s interest in DynPort and became the parent company. CSC split in late 2015 and its public sector segment merged with SRA International to become CSRA Inc.
” See: “A vaccine against the plague? This Maryland company is on it” Mar 9, 2017, By Tina Reed, Washington Business Journal https://web.archive.org/web/20170318030940/https://www.bizjournals.com/washington/news/2017/03/09/why-a-maryland-company-is.html

Department of Defense (DoD) Chemical Biological Medical Systems-Joint Vaccine Acquisition Program (CBMS-JVAP) contract. DVC has served as prime systems contractor for CBMS-JVAP since 1997. The safety and efficacy of this product in humans has not been established. The product is currently under clinical investigation and has not been licensed by the FDA. This study was funded by CBMS-JVAP, DoD Contract DAMD17-98-C-8024 and does not represent official DoD positions, policies or decisions.” See: “ CSC’s DynPort Vaccine Company Completes Vaccinations and Study Visits in Phase 2 Botulinum Vaccine Clinical Trial” Feb 24, 2011 8:25am https://web.archive.org/web/20220112003430/https://www.fiercebiotech.com/biotech/csc-s-dynport-vaccine-company-completes-vaccinations-and-study-visits-phase-2-botulinum

Related: https://www.organicconsumers.org/blog/dr-robert-kadlec-how-czar-biowarfare-funnels-billions-friends-vaccine-industry